BEng (Hons), MSc, MBA, MPA, PhD
Joined the group in 2014
Dr Michael Neoptolemou is a seasoned academic and a PhD graduate whose illustrious career spans the public, higher education and corporate sectors. He has been a member of the top management of Remedica since 2014. He joined the board of directors in 2017 and currently serves as its chairman. In July 2019, he was appointed as the company’s Group Chief Executive Officer. Under his leadership, Remedica has increased its Research and Development (R&D) activities, invested in the development of new pharmaceutical products to its portfolio while maximising the revenue and profitability.
Attila is an accomplished finance professional with a proven track record of delivering on stretch commitments, building high-performing teams, and driving sustainable business change. Attila joined Scitec in 2014 as CFO but also served a 4-month tenure as Interim CEO of Scitec from March to June 2017.
In 2018, following the launch of the Scitec Institute (SI), he was appointed the CEO of SI. Effective as of 1st of July 2019, Attila was been appointed as the interim CEO of Scitec.
Prior to joining Scitec, Attila held senior management positions at multinationals GE, Deutsche Telekom and Graphisoft.
B Sc (Chemistry)
Joined the group in June 2017
Yogish has over 25 years international pharmaceutical experience, including serving as country head of Ranbaxy Romania and holding senior positions for Sun Pharmaceuticals in India, Africa and Ukraine. He founded Sun Wave Pharma in 2008 and has grown the business into one of the leading pharma companies in Romania, ranked number one in the nutraceuticals market.
Graduated in Economics (CEU – University of Madrid); 3 years of Marketing at ESIC (Escuela Superior de Ingenieros Comerciales)
Joined the group in 2015
José Luis founded Farmalider in 1986, bringing more than 30 years experience in the pharmaceutical industry to the company. He previously founded Laboratorio Lanzas, Laboratorio Beneline and Lineafarm. Prior to that he spent five years at Sofemasa, a Spanish consulting company.
B.Acc, B.Acc (Hon), CA(SA)
Joined the group in July 2018
Marnus has a strong and diverse background in private equity, management consulting and accounting. His career includes eight years with global management consulting firm McKinsey & Company where he gained exposure to several sectors and industries. He was previously a director of Coast2Coast Capital for two years, responsible for value creation.
Joined the group in 2009
Chris has over 26 years’ experience in an extensive range of Medical Devices with a vast amount of time spent in Interventional & Hemodynamic Areas. During this time, he worked for Adcock Ingram, B Braun and Brittan Healthcare where he successfully ran the business for the Marconi family before it was sold. During this period, he was involved in various Sales, Marketing and operational roles. Chris was a co-owner of the interventional business that was sold out of Brittan Healthcare. Chris was a shareholder in Surgical Innovations when this business was sold to Ascendis in 2014.
B Com (Hons Marketing), CM (SA)
Joined the group in 2017
Lee-Ann has over 15 years FMCG experience, including four years in the cosmetics industry. She was previously brand general manager for MAC Cosmetics, Estee Lauder, Aerin and Tom Ford. Lee-Ann spent 10 years at SAB focusing mainly on the premium beer portfolio.
MBA and BVSc (Veterinary Sciences)
Joined the group in 2017
Jan has over 20 years of experience in the animal health pharmaceutical industry. Over this time he held various roles within regulatory affairs, clinical development and sales and marketing. He spent 9 years in senior roles at Pfizer Animal Health and in 2004 joined Cipla Agrimed as Managing Director. Following the acquisition of Cipla Agrimed SA and Cipla Vet SA by Ascendis Health in 2017, Jan was appointed Managing Director of Animal Health